PMID- 37496681
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230728
IS  - 1664-0640 (Print)
IS  - 1664-0640 (Electronic)
IS  - 1664-0640 (Linking)
VI  - 14
DP  - 2023
TI  - Psychoactive substance use in patients diagnosed with 
      attention-deficit/hyperactivity disorder: an exploratory study.
PG  - 1184023
LID - 10.3389/fpsyt.2023.1184023 [doi]
LID - 1184023
AB  - INTRODUCTION: Attention-deficit/hyperactivity disorder (ADHD) was originally 
      treated as a neurodevelopmental disorder that occurs mainly in children and tends 
      to diminish or disappear with age, but we now know that symptoms persist into 
      adulthood in over 50% of ADHD patients. Undiagnosed individuals often turn to 
      psychoactive substance to minimize the negative aspects of functioning and 
      improve quality of life. METHODS: The study was conducted online using random 
      sampling through a Facebook group administered by physicians and targeted to 
      patients diagnosed with ADHD. The study was naturalistic and exploratory, 
      therefore no hypothesis was made. 438 correctly completed questionnaires were 
      received. Analysis of the results showed that people with ADHD turn to 
      psychoactive substances relatively frequently. RESULTS: The most commonly used 
      stimulants include alcohol, marijuana, 3,4-methylenedioxymethamphetamine (MDMA), 
      amphetamine/methamphetamine, and psilocybin. In the study population, 
      methylphenidate is the most commonly used drug among patients. After treatment 
      with psychostimulants, the majority of respondents note a decrease in symptoms of 
      hyperactivity disorder, especially in male patients. CONCLUSION: It is necessary 
      to perform proper diagnostics and actively look for ADHD symptoms in patients who 
      tend to use psychoactive substances.
CI  - Copyright (c) 2023 Wieckiewicz, Stoklosa, Stoklosa, Wieckiewicz, Gorczyca and 
      Gondek.
FAU - Wieckiewicz, Gniewko
AU  - Wieckiewicz G
AD  - Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical 
      University of Silesia, Katowice, Poland.
FAU - Stoklosa, Iga
AU  - Stoklosa I
AD  - Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical 
      University of Silesia, Katowice, Poland.
FAU - Stoklosa, Maciej
AU  - Stoklosa M
AD  - Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical 
      University of Silesia, Katowice, Poland.
FAU - Wieckiewicz, Wlodzimierz
AU  - Wieckiewicz W
AD  - Department of Prosthodontics, Faculty of Dentistry, Wroclaw Medical University, 
      Wroclaw, Poland.
FAU - Gorczyca, Piotr
AU  - Gorczyca P
AD  - Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical 
      University of Silesia, Katowice, Poland.
FAU - Gondek, Tomasz M
AU  - Gondek TM
AD  - Iter Psychology Practices, Wroclaw, Poland.
LA  - eng
PT  - Journal Article
DEP - 20230711
PL  - Switzerland
TA  - Front Psychiatry
JT  - Frontiers in psychiatry
JID - 101545006
PMC - PMC10366592
OTO - NOTNLM
OT  - ADHD
OT  - addiction
OT  - addiction psychiatry
OT  - psychoactive substance
OT  - psychoactive substance abuse
COIS- GW received honoraria for lectures from: Angelini Pharma Polska and support for 
      attending meetings from: Angelini Pharma Polska, Apotex Poland/Aurovitas Pharma 
      Polska, Lek-AM. IS received support for attending meetings from: Lek-AM. TG 
      received honoraria for lectures from: Valeant Polska, Lundbeck Poland, Apotex 
      Poland/Aurovitas Pharma Polska, Celon Pharma and support for attending meetings 
      from: Lundbeck Poland, EGIS, GL Pharma. The remaining authors declare that the 
      research was conducted in the absence of any commercial or financial 
      relationships that could be construed as a potential conflict of interest.
EDAT- 2023/07/27 06:42
MHDA- 2023/07/27 06:43
PMCR- 2023/07/11
CRDT- 2023/07/27 04:00
PHST- 2023/03/10 00:00 [received]
PHST- 2023/06/27 00:00 [accepted]
PHST- 2023/07/27 06:43 [medline]
PHST- 2023/07/27 06:42 [pubmed]
PHST- 2023/07/27 04:00 [entrez]
PHST- 2023/07/11 00:00 [pmc-release]
AID - 10.3389/fpsyt.2023.1184023 [doi]
PST - epublish
SO  - Front Psychiatry. 2023 Jul 11;14:1184023. doi: 10.3389/fpsyt.2023.1184023. 
      eCollection 2023.